These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26867503)

  • 21. α7 Nicotinic receptor agonist enhances cognition in aged 3xTg-AD mice with robust plaques and tangles.
    Medeiros R; Castello NA; Cheng D; Kitazawa M; Baglietto-Vargas D; Green KN; Esbenshade TA; Bitner RS; Decker MW; LaFerla FM
    Am J Pathol; 2014 Feb; 184(2):520-9. PubMed ID: 24269557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New racemic annulated pyrazolo[1,2-b]phthalazines as tacrine-like AChE inhibitors with potential use in Alzheimer's disease.
    Jalili-Baleh L; Nadri H; Moradi A; Bukhari SNA; Shakibaie M; Jafari M; Golshani M; Homayouni Moghadam F; Firoozpour L; Asadipour A; Emami S; Khoobi M; Foroumadi A
    Eur J Med Chem; 2017 Oct; 139():280-289. PubMed ID: 28803044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.
    Wilkinson DG; Francis PT; Schwam E; Payne-Parrish J
    Drugs Aging; 2004; 21(7):453-78. PubMed ID: 15132713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time-dependent effect of oligomeric amyloid-β (1-42)-induced hippocampal neurodegeneration in rat model of Alzheimer's disease.
    Karthick C; Nithiyanandan S; Essa MM; Guillemin GJ; Jayachandran SK; Anusuyadevi M
    Neurol Res; 2019 Feb; 41(2):139-150. PubMed ID: 30453864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reducing amyloid-related Alzheimer's disease pathogenesis by a small molecule targeting filamin A.
    Wang HY; Bakshi K; Frankfurt M; Stucky A; Goberdhan M; Shah SM; Burns LH
    J Neurosci; 2012 Jul; 32(29):9773-84. PubMed ID: 22815492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uleine Disrupts Key Enzymatic and Non-Enzymatic Biomarkers that Leads to Alzheimer's Disease.
    Seidl C; de Moraes Santos CA; De Simone A; Bartolini M; Weffort-Santos AM; Andrisano V
    Curr Alzheimer Res; 2017; 14(3):317-326. PubMed ID: 27784218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroprotective and Neurotoxic Implications of α7 Nicotinic Acetylcholine Receptor and Aβ Interaction: Therapeutic Options in Alzheimer's Disease.
    Farhat SM; Ahmed T
    Curr Drug Targets; 2017; 18(13):1537-1544. PubMed ID: 27719660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On the interaction of β-amyloid peptides and α7-nicotinic acetylcholine receptors in Alzheimer's disease.
    Oz M; Lorke DE; Yang KH; Petroianu G
    Curr Alzheimer Res; 2013 Jul; 10(6):618-30. PubMed ID: 23627750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An update on the pharmacology of galantamine.
    Villarroya M; García AG; Marco-Contelles J; López MG
    Expert Opin Investig Drugs; 2007 Dec; 16(12):1987-98. PubMed ID: 18042006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis and evaluation of pterostilbene β-amino alcohol derivatives as multifunctional agents for Alzheimer's disease treatment.
    Zheng Y; Qiang X; Xu R; Song Q; Tian C; Liu H; Li W; Tan Z; Deng Y
    Bioorg Chem; 2018 Aug; 78():298-306. PubMed ID: 29625269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peptide-Based Acetylcholinesterase Inhibitor Crosses the Blood-Brain Barrier and Promotes Neuroprotection.
    Mondal P; Gupta V; Das G; Pradhan K; Khan J; Gharai PK; Ghosh S
    ACS Chem Neurosci; 2018 Nov; 9(11):2838-2848. PubMed ID: 30015476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-Stearoylethanolamine protects the brain and improves memory of mice treated with lipopolysaccharide or immunized with the extracellular domain of α7 nicotinic acetylcholine receptor.
    Lykhmus O; Uspenska K; Koval L; Lytovchenko D; Voytenko L; Horid'ko T; Kosiakova H; Gula N; Komisarenko S; Skok M
    Int Immunopharmacol; 2017 Nov; 52():290-296. PubMed ID: 28963942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reducing iron in the brain: a novel pharmacologic mechanism of huperzine A in the treatment of Alzheimer's disease.
    Huang XT; Qian ZM; He X; Gong Q; Wu KC; Jiang LR; Lu LN; Zhu ZJ; Zhang HY; Yung WH; Ke Y
    Neurobiol Aging; 2014 May; 35(5):1045-54. PubMed ID: 24332448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lynx1 and Aβ1-42 bind competitively to multiple nicotinic acetylcholine receptor subtypes.
    Thomsen MS; Arvaniti M; Jensen MM; Shulepko MA; Dolgikh DA; Pinborg LH; Härtig W; Lyukmanova EN; Mikkelsen JD
    Neurobiol Aging; 2016 Oct; 46():13-21. PubMed ID: 27460145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of amyloid peptides on the increase in TrkA receptor expression induced by nicotine in vitro and in vivo.
    Li XD; Arias E; Jonnala RR; Mruthinti S; Buccafusco JJ
    J Mol Neurosci; 2005; 27(3):325-36. PubMed ID: 16280603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antagonising a novel toxin "T14" in Alzheimer's disease: Comparison of receptor blocker versus antibody effects in vitro.
    Hasan S; Ahmed M; Garcia-Ratés S; Greenfield S
    Biomed Pharmacother; 2023 Feb; 158():114120. PubMed ID: 36521245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting brain α7 nicotinic acetylcholine receptors in Alzheimer's disease: rationale and current status.
    Vallés AS; Borroni MV; Barrantes FJ
    CNS Drugs; 2014 Nov; 28(11):975-87. PubMed ID: 25248971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Huperzine A and tacrine attenuate beta-amyloid peptide-induced oxidative injury.
    Xiao XQ; Wang R; Tang XC
    J Neurosci Res; 2000 Sep; 61(5):564-9. PubMed ID: 10956426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Substantial Neuroprotective and Neurite Outgrowth-Promoting Activities by Bis(propyl)-cognitin via the Activation of Alpha7-nAChR, a Promising Anti-Alzheimer's Dimer.
    Hu S; Cui W; Mak S; Xu D; Hu Y; Tang J; Choi C; Lee M; Pang Y; Han Y
    ACS Chem Neurosci; 2015 Sep; 6(9):1536-45. PubMed ID: 26147504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitogen-activated protein kinase signaling pathways are involved in regulating α7 nicotinic acetylcholine receptor-mediated amyloid-β uptake in SH-SY5Y cells.
    Yang WN; Ma KG; Chen XL; Shi LL; Bu G; Hu XD; Han H; Liu Y; Qian YH
    Neuroscience; 2014 Oct; 278():276-90. PubMed ID: 25168732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.